IL104026A - A drug for the improvement of dysuria containing a history of xanthine - Google Patents

A drug for the improvement of dysuria containing a history of xanthine

Info

Publication number
IL104026A
IL104026A IL10402692A IL10402692A IL104026A IL 104026 A IL104026 A IL 104026A IL 10402692 A IL10402692 A IL 10402692A IL 10402692 A IL10402692 A IL 10402692A IL 104026 A IL104026 A IL 104026A
Authority
IL
Israel
Prior art keywords
denotes
carbon atoms
dysuria
improvement
group
Prior art date
Application number
IL10402692A
Other languages
English (en)
Hebrew (he)
Other versions
IL104026A0 (en
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of IL104026A0 publication Critical patent/IL104026A0/xx
Publication of IL104026A publication Critical patent/IL104026A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10402692A 1991-12-10 1992-12-08 A drug for the improvement of dysuria containing a history of xanthine IL104026A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3325458A JP2549480B2 (ja) 1991-12-10 1991-12-10 排尿障害改善剤

Publications (2)

Publication Number Publication Date
IL104026A0 IL104026A0 (en) 1993-05-13
IL104026A true IL104026A (en) 1995-11-27

Family

ID=18177097

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10402692A IL104026A (en) 1991-12-10 1992-12-08 A drug for the improvement of dysuria containing a history of xanthine

Country Status (18)

Country Link
US (1) US5496823A (ko)
EP (1) EP0546547B1 (ko)
JP (1) JP2549480B2 (ko)
KR (1) KR930012019A (ko)
CN (1) CN1073861A (ko)
AT (1) ATE110569T1 (ko)
AU (1) AU656443B2 (ko)
CA (1) CA2084962A1 (ko)
CZ (1) CZ282422B6 (ko)
DE (1) DE69200365T2 (ko)
DK (1) DK0546547T3 (ko)
ES (1) ES2062860T3 (ko)
HU (2) HUT63055A (ko)
IL (1) IL104026A (ko)
MX (1) MX9207123A (ko)
PH (1) PH30691A (ko)
TW (1) TW210286B (ko)
ZA (1) ZA929529B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
DE19529102A1 (de) * 1995-08-08 1997-02-13 Kummer Horst Dieter Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen
WO1998011888A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
WO2020186187A1 (en) * 2019-03-13 2020-09-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for treating bladder and urethra dysfunction and disease
WO2021065027A1 (ja) 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
MX2022003983A (es) 2019-10-02 2022-04-26 Aska Pharm Co Ltd Agente mejorador de los trastornos de la miccion.
TW202241452A (zh) 2020-12-18 2022-11-01 日商Ａｓｋａ製藥股份有限公司 固形製劑

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
MX9207123A (es) 1993-07-30
CA2084962A1 (en) 1993-06-11
HUT63055A (en) 1993-07-28
ATE110569T1 (de) 1994-09-15
EP0546547B1 (en) 1994-08-31
AU656443B2 (en) 1995-02-02
JP2549480B2 (ja) 1996-10-30
TW210286B (ko) 1993-08-01
PH30691A (en) 1997-09-16
US5496823A (en) 1996-03-05
AU2998592A (en) 1993-06-17
DE69200365T2 (de) 1995-02-16
DE69200365D1 (de) 1994-10-06
DK0546547T3 (da) 1995-02-13
CZ282422B6 (cs) 1997-07-16
JPH05155773A (ja) 1993-06-22
KR930012019A (ko) 1993-07-20
HU9203911D0 (en) 1993-03-29
ES2062860T3 (es) 1994-12-16
CZ361192A3 (en) 1993-09-15
CN1073861A (zh) 1993-07-07
ZA929529B (en) 1993-06-15
IL104026A0 (en) 1993-05-13
EP0546547A1 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
KR0148589B1 (ko) 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
KR100874815B1 (ko) 간질성 방광염 치료용 의약 조성물
KR20010080053A (ko) 말초 작용 항소양 아편제
AU610822B2 (en) Anti-dementia agents
US5496823A (en) Pharmaceutical composition for increasing bladder capacity
US6218411B1 (en) Therapeutics for diabetic complications
CA1117419A (en) Pharmaceutical compositions containing a xanthine derivative
US4719212A (en) Therapeutic agent for memory disturbance
KR20000064939A (ko) 디하이드로피리딘화합물을함유하는안조직말초순환개선제
KR950007101B1 (ko) 소화성 궤양 치료제
HUT50440A (en) Process for producing pharmaceutical compositions for treating schizophrenia
US20040106671A1 (en) Remedies for vesical hyperesthesia
WO2005007191A1 (ja) 医薬組成物
KR100194825B1 (ko) 말초 순환 개선제
US4721714A (en) Anti-vertigo drug
UA146735U (uk) Фармацевтичний препарат для лікування болю та запалення
CA1263843A (en) Treatment of sleep disorders
JPH1067661A (ja) 記憶障害治療剤
JPH02223523A (ja) 不安及び不眠症の治療のための薬剤
IE52176B1 (en) Pharmaceutical compositions containing a xanthine derivative
KR19980703816A (ko) 레보부피바카인 및 임산부의 마취제로서 그것의 용도
JPS63145231A (ja) ステロイド化合物を含有する脳機能賦活剤

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees